Analysts Viewpoint
Investing in Immunome Inc (IMNM): What You Must Know
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Menu
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Immunome Inc revealed its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $60684.0 on Mar 25
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $60684.0 on Mar 25 ’25.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Immunome Inc